Posts in Products
Cresemba

Cresemba (isavuconazonium) is an antifungal medication that fights infections caused by fungus. Cresemba is used to treat infections caused by certain types of fungus (aspergillosis or mucormycosis).

Read More
Productsparisiva—
Natulan

Natulan contains  procarbazine, which intervenes in the cell division cycle and prevents the growth of different types of cancer cells.
Natulan is used in combination with other anticancer drugs in the treatment of Hodgkin's and non-Hodgkin's lymphomas

Read More
Soliris

Soliris (eculizumab) is a monoclonal antibody. Eculizumab binds to proteins in the blood that can destroy red blood cells in people with genetic conditions that affect the natural defenses of red blood cells.

Read More
Productsparisiva—
Norgesic

Norgesic (aspirin/caffeine/orphenadrine) is used, along with rest and physical therapy, to treat injuries and other painful muscular conditions.

Read More
Productsparisiva—
Abraxane

Abraxane (paclitaxel protein-bound) is a member of the mitotic inhibitors drug class and is commonly used for Breast Cancer, Breast Cancer - Metastatic, Non-Small Cell Lung Cancer and others.

Read More
Productsparisiva—
Epclusa

Epclusa contains a combination of sofosbuvir and velpatasvir. Sofosbuvir and velpatasvir are antiviral medications that prevent hepatitis C virus (HCV) from multiplying in your body.

Read More
Productsparisiva—
Erwinase

Erwinase (asparaginase Erwinia chrysanthemi) is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived Erwinase.

Read More
Productsparisiva—
Giotrif

Giotrif is a medicine used to treat a type of lung cancer known as non-small cell lung cancer. The active substance in Giotrif, afatinib, is an ErbB family blocker.

Read More
Productsparisiva—
Imfinzi

Imfinzi (durvalumab) is a cancer medicine that works with your immune system to interfere with the growth and spread of cancer cells in the body.

Read More
Productsparisiva—
Keytruda

Keytruda (pembrolizumab) is a human PD-1 (programmed death receptor-1)-blocking antibody indicated for the treatment of melanoma, non-small cell lung cancer, head and neck squamous cell carcinoma, classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, urothelial carcinoma, microsatellite instability-high cancer, gastric cancer, cervical cancer, hepatocellular carcinoma, and Merkel cell carcinoma.

Read More
Productsparisiva—
MabThera

MabThera is the first therapeutic monoclonal antibody to target cells that have the CD20 marker on their surface. These cells are central to many blood cancers, including common forms of lymphoma and leukaemia. MabThera attacks these cells both directly and together with the body’s immune system.

Read More
Productsparisiva—